Aduro Biotech (ADRO) Short Interest Ratio & Short Volume → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free ADRO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Aduro Biotech Short Interest DataCurrent Short Volume3,210,000 sharesPrevious Short Volume3,300,000 sharesChange Vs. Previous Month-2.73%Dollar Volume Sold Short$7.75 millionShort Interest Ratio / Days to Cover6.1Last Record DateSeptember 15, 2020Outstanding Shares16,212,000 sharesFloat Size50,970,000 sharesShort Percent of Float6.30%Today's Trading Volume171,500 sharesAverage Trading Volume162,237 sharesToday's Volume Vs. Average106% Short Selling Aduro Biotech ? Sign up to receive the latest short interest report for Aduro Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADRO Short Interest Over TimeADRO Days to Cover Over TimeADRO Percentage of Float Shorted Over Time Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Aduro Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20203,210,000 shares $7.75 million -2.7%6.3%6.1 $2.42 8/31/20203,300,000 shares $10.23 million -9.3%6.5%6.1 $3.10 8/14/20203,640,000 shares $8.74 million -5.7%7.2%5.6 $2.40 7/31/20203,860,000 shares $10.89 million -3.7%7.6%6.8 $2.82 7/15/20204,010,000 shares $11.35 million +23.0%8.6%6.9 $2.83 6/30/20203,260,000 shares $7.30 million +4.2%7.0%5.4 $2.24 6/15/20203,130,000 shares $6.98 million +7.2%6.7%5.4 $2.23 5/29/20202,920,000 shares $9.52 million +6.6%6.3%4.6 $3.26 5/15/20202,740,000 shares $7.37 million +4.2%5.8%4.4 $2.69 4/30/20202,630,000 shares $7.27 million -11.2%4.3%3 $2.77 4/15/20202,960,000 shares $9.35 million -7.5%4.8%2.6 $3.16 3/31/20203,200,000 shares $8.77 million -5.2%6.2%2.6 $2.74 3/13/20203,375,100 shares $8.64 million -2.2%6.6%4.3 $2.56 2/28/20203,450,000 shares $10.52 million +8.5%6.8%2.7 $3.05 2/14/20203,180,000 shares $10.75 million +30.3%6.2%2.5 $3.38 1/31/20202,440,000 shares $4.10 million +24.5%4.8%2 $1.68 1/15/20201,960,000 shares $2.41 million +2.1%3.8%2.1 $1.23 12/31/20191,920,000 shares $2.27 million -1.0%3.8%2.1 $1.18 8/15/20191,461,300 shares $1.94 million -18.1%3.2%3.2 $1.33 ADRO Short Interest - Frequently Asked Questions What is Aduro Biotech's current short interest? Short interest is the volume of Aduro Biotech shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 3,210,000 shares of ADRO short. 6.30% of Aduro Biotech's shares are currently sold short. Learn More on Aduro Biotech's current short interest. What is a good short interest ratio for Aduro Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADRO shares currently have a short interest ratio of 6.0. Learn More on Aduro Biotech's short interest ratio. What is a good short interest percentage for Aduro Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.30% of Aduro Biotech's floating shares are currently sold short. Is Aduro Biotech's short interest increasing or decreasing? Aduro Biotech saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 3,210,000 shares, a drop of 2.7% from the previous total of 3,300,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aduro Biotech's float size? Aduro Biotech currently has issued a total of 16,212,000 shares. Some of Aduro Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aduro Biotech currently has a public float of 50,970,000 shares. How does Aduro Biotech's short interest compare to its competitors? 6.30% of Aduro Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aduro Biotech: Immutep Limited (1.43%), 23andMe Holding Co. (11.72%), Galectin Therapeutics Inc. (5.31%), Conduit Pharmaceuticals Inc. (0.53%), Atossa Therapeutics, Inc. (8.43%), Nektar Therapeutics (1.32%), Ovid Therapeutics Inc. (4.78%), Werewolf Therapeutics, Inc. (1.61%), Gossamer Bio, Inc. (4.77%), uniQure (5.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.24 billion), Aon plc ($3.67 billion), The Clorox Company ($2.89 billion), The Charles Schwab Co. ($2.79 billion), MercadoLibre, Inc. ($2.26 billion), Analog Devices, Inc. ($2.19 billion), Simon Property Group, Inc. ($2.01 billion), The Kroger Co. ($1.94 billion), Moderna, Inc. ($1.89 billion), and International Flavors & Fragrances Inc. ($1.81 billion). View all of the most shorted stocks. What does it mean to sell short Aduro Biotech stock? Short selling ADRO is an investing strategy that aims to generate trading profit from Aduro Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aduro Biotech? A short squeeze for Aduro Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADRO, which in turn drives the price of the stock up even further. How often is Aduro Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADRO, twice per month. The most recent reporting period available is September, 15 2020. More Short Interest Resources from MarketBeat Related Companies: IMMP Short Interest ME Short Interest GALT Short Interest CDT Short Interest ATOS Short Interest NKTR Short Interest OVID Short Interest HOWL Short Interest GOSS Short Interest QURE Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADRO) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsOptions trading has suddenly become more reliable.Eagle PublishingYou won't believe what Citigroup just did to it's depositorsAmerican Alternative